Amane Kozuki

Osaka, 5300012, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Subclinical intimal injury visualized by optical frequency domain imaging and angioscopy after radiofrequency renal denervation.

Subclinical intimal injury visualized by optical frequency domain imaging and angioscopy after radiofrequency renal denervation.

Journal: Cardiovascular intervention and therapeutics

Published: May 19, 2026

Three-year outcomes of the TCD-17187 (Kanshas) drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery.

Three-year outcomes of the TCD-17187 (Kanshas) drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery.

Journal: CVIR endovascular

Published: January 28, 2026

Drug-Coated Balloon Versus Drug-Eluting Stent for Femoropopliteal Lesions: A 3-Year Propensity Score-Matched Analysis.

Drug-Coated Balloon Versus Drug-Eluting Stent for Femoropopliteal Lesions: A 3-Year Propensity Score-Matched Analysis.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: November 15, 2025

Impact of Repeated Drug-Coated Balloon for Restenosis Following Femoropopliteal Drug-Coated Balloon Treatment.

Impact of Repeated Drug-Coated Balloon for Restenosis Following Femoropopliteal Drug-Coated Balloon Treatment.

Journal: JACC. Cardiovascular interventions

Published: September 22, 2025

Optical coherence tomography-guided stent optimization and clinical outcomes in all-comer patients with ST-elevation myocardial infarction.

Optical coherence tomography-guided stent optimization and clinical outcomes in all-comer patients with ST-elevation myocardial infarction.

Journal: European heart journal. Cardiovascular Imaging

Published: August 21, 2025

Long-term results of the RANGER II SFA randomized trial of the Ranger drug-coated balloon vs standard percutaneous transluminal angioplasty for femoropopliteal artery treatment.

Long-term results of the RANGER II SFA randomized trial of the Ranger drug-coated balloon vs standard percutaneous transluminal angioplasty for femoropopliteal artery treatment.

Journal: Vascular medicine (London, England)

Published: July 21, 2025

3-Year Results Following Femoropopliteal Lesion Treatment With a Novel Sirolimus-Eluting Balloon.

3-Year Results Following Femoropopliteal Lesion Treatment With a Novel Sirolimus-Eluting Balloon.

Journal: JACC. Cardiovascular interventions

Published: June 20, 2025

Effectiveness of cilostazol treatment in femoropopliteal artery disease after drug-coated balloon therapy: Subanalysis of the POPCORN study.

Effectiveness of cilostazol treatment in femoropopliteal artery disease after drug-coated balloon therapy: Subanalysis of the POPCORN study.

Journal: Journal of vascular surgery

Published: June 16, 2025

Long-term effects of statin and anticoagulant therapy on restenosis after drug-coated balloon angioplasty for femoropopliteal artery disease: results from the POPCORN registry.

Long-term effects of statin and anticoagulant therapy on restenosis after drug-coated balloon angioplasty for femoropopliteal artery disease: results from the POPCORN registry.

Journal: Cardiovascular intervention and therapeutics

Published: May 24, 2025

Feasibility of optical coherence tomography-guided primary percutaneous coronary intervention for STEMI: all-comer ATLAS-OCT trial.

Feasibility of optical coherence tomography-guided primary percutaneous coronary intervention for STEMI: all-comer ATLAS-OCT trial.

Journal: Cardiovascular intervention and therapeutics

Published: February 22, 2025

Efficacy and safety of emergent balloon aortic valvuloplasty as a rescue therapy for cardiogenic shock due to severe aortic stenosis in non-TAVI centers.

Efficacy and safety of emergent balloon aortic valvuloplasty as a rescue therapy for cardiogenic shock due to severe aortic stenosis in non-TAVI centers.

Journal: BMC cardiovascular disorders

Published: February 09, 2025

Efficacy of Rheocarna®, a Novel Apheresis Device, in Patients With No- or Poor-Option Chronic Limb-Threatening Ischemia.

Efficacy of Rheocarna®, a Novel Apheresis Device, in Patients With No- or Poor-Option Chronic Limb-Threatening Ischemia.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: January 29, 2025

Showing 1-12 of 81

Last Updated: 09/26/2026